|
PPP3CA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.109190E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.003230E-01 |
| Normal-vs-Stage2 |
6.112400E-01 |
| Normal-vs-Stage3 |
2.088800E-01 |
| Normal-vs-Stage4 |
5.953800E-01 |
| Stage1-vs-Stage2 |
5.616600E-01 |
| Stage1-vs-Stage3 |
9.224600E-01 |
| Stage1-vs-Stage4 |
4.809800E-01 |
| Stage2-vs-Stage3 |
6.632400E-01 |
| Stage2-vs-Stage4 |
9.478600E-01 |
| Stage3-vs-Stage4 |
5.789600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.465600E-01 |
| Normal-vs-AfricanAmerican |
3.514200E-02 |
| Normal-vs-Asian |
1.391200E-01 |
| Caucasian-vs-AfricanAmerican |
9.817700E-02 |
| Caucasian-vs-Asian |
4.477400E-01 |
| AfricanAmerican-vs-Asian |
4.139600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.623160E-01 |
| Normal-vs-Female |
1.313580E-01 |
| Male-vs-Female |
9.229400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.182150E-01 |
| Normal-vs-Age(41-60Yrs) |
1.539980E-01 |
| Normal-vs-Age(61-80Yrs) |
7.142000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.009600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.475600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.590400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.876600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.277600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.362000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.737400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.372000E-01 |
| Classical-VS-Follicular |
3.66750000000415E-05 |
| Classical-VS-Other |
5.518200E-01 |
| Classical-VS-Normal |
7.539500E-03 |
| Tall-VS-Follicular |
2.126300E-02 |
| Tall-VS-Other |
6.144400E-01 |
| Tall-VS-Normal |
1.102210E-01 |
| Follicular-VS-Other |
4.451200E-01 |
| Follicular-VS-Normal |
2.127600E-01 |
| Other-VS-Normal |
7.305800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.277400E-01 |
| Normal-vs-N1 |
8.393600E-01 |
| N0-vs-N1 |
9.549800E-01 |
|
|
